Atlantic Coastal Acquisition Corp. II to Merge with 03 Life Sciences
Ticker: ABPWW · Form: 8-K · Filed: Aug 19, 2024 · CIK: 1893219
| Field | Detail |
|---|---|
| Company | Atlantic Coastal Acquisition CORP. II (ABPWW) |
| Form Type | 8-K |
| Filed Date | Aug 19, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: merger, acquisition, life-sciences
TL;DR
ACQII merging with 03 Life Sciences, deal expected Q4 2024.
AI Summary
Atlantic Coastal Acquisition Corp. II announced on August 16, 2024, that it has entered into a definitive agreement to merge with 03 Life Sciences. The transaction is expected to close in the fourth quarter of 2024, subject to customary closing conditions.
Why It Matters
This merger signifies a strategic move for Atlantic Coastal Acquisition Corp. II to combine with a company in the biological products sector, potentially impacting its future growth and market position.
Risk Assessment
Risk Level: medium — Mergers and acquisitions inherently carry risks related to integration, market reception, and regulatory approval.
Key Numbers
- Q4 2024 — Expected Closing Quarter (Timeline for the completion of the merger)
Key Players & Entities
- Atlantic Coastal Acquisition Corp. II (company) — Registrant
- 03 Life Sciences (company) — Target company in merger
- August 16, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- New York (location) — Principal executive office location
FAQ
What is the primary business of 03 Life Sciences?
The filing indicates that Atlantic Coastal Acquisition Corp. II's Standard Industrial Classification is 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]', suggesting 03 Life Sciences operates in this sector.
What is the expected closing date for the merger?
The merger is expected to close in the fourth quarter of 2024.
What are the key conditions for the merger to close?
The merger is subject to customary closing conditions.
What is the ticker symbol for Atlantic Coastal Acquisition Corp. II?
The filing does not explicitly state the ticker symbol, but the SEC file number is 001-41224.
What type of securities are involved in the merger?
The filing mentions 'Units, each consisting of one share of Series A common stock, $0.0001 par value, and one-half of one redeemable warrant', which are associated with Atlantic Coastal Acquisition Corp. II.
Filing Stats: 488 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2024-08-19 16:02:04
Key Financial Figures
- $0.0001 — of one share of Series A common stock, $0.0001 par value, and one-half of one redeemab
- $11.50 — A common stock at an exercise price of $11.50 ACABW The Nasdaq Stock Market LLC
Filing Documents
- d883725d8k.htm (8-K) — 25KB
- 0001193125-24-202807.txt ( ) — 185KB
- acab-20240816.xsd (EX-101.SCH) — 3KB
- acab-20240816_def.xml (EX-101.DEF) — 14KB
- acab-20240816_lab.xml (EX-101.LAB) — 23KB
- acab-20240816_pre.xml (EX-101.PRE) — 15KB
- d883725d8k_htm.xml (XML) — 7KB
From the Filing
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 16, 2024 ATLANTIC COASTAL ACQUISITION CORP. II (Exact name of registrant as specified in its charter) Delaware 001-41224 87-1013956 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 6 St Johns Lane, Floor 5 New York , NY 10013 (Address of principal executive offices) (Zip Code) ( 248 ) 890-7200 (Registrant's telephone number, including area code) N/A (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Units, each consisting of one share of Series A common stock, $0.0001 par value, and one-half of one redeemable warrant ACABU The Nasdaq Stock Market LLC Shares of Series A common stock included as part of the units ACAB The Nasdaq Stock Market LLC Warrants included as part of the units, each whole warrant exercisable for one share of Series A common stock at an exercise price of $11.50 ACABW The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item8.01 Other Events. On August 16, 2024, Atlantic Coastal Acquisition Corp. II (the "Company"), by resolution of the board of directors of the Company, in accordance with the Company's Amended and Restated Certificate of Incorporation (as amended), extended the expiration date of the amount of time that the Company has available to complete a business combination from August 19, 2024 to September 19, 2024. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 19, 2024 ATLANTIC COASTAL ACQUISITION CORP. II By: /s/ Shahraab Ahmad Shahraab Ahmad Chief Executive Officer